Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm.

Hematology/oncology clinics of North America - 1 Jun 2020

Lane Andrew A

Abstract excerpt

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an orphan hematologic malignancy with poor outcomes. Tagraxofusp (SL-401) was the first drug approved specifically for patients with BPDCN, in 2018. Additional therapeutic strategies are still needed to improve survival and minimize treatment-related toxicity. This article outlines novel targeted approaches that are in preclinical or clinical development for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bridged Bicyclo Compounds, Heterocyclic
Share to Dendritic Cells
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Myeloproliferative Disorders

Share to Neoplasms, Second Primary

Share to Proto-Oncogene Proteins c-bcl-2

Share to Sulfonamides

Source

Identifiers

PMID: 32336422
DOI: 10.1016/j.hoc.2020.01.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm.PMID 32336422Read ↗

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).Semantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm: Updates in Diagnostic and Molecular Pathology.Semantic proximity Read ↗

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.Semantic proximity Read ↗

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.Semantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.Semantic proximity Read ↗

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read ↗

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights From Countries of the Gulf Cooperation CouncilSemantic proximity Read ↗

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.Semantic proximity Read ↗

Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.Semantic proximity Read ↗

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic targetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.